Pancreatitis Forces Halt to HCV Drug Trial
(MedPage Today) — Three cases of acute pancreatitis, one fatal, have led the FDA to put a clinical hold on a trial of an investigational oral drug for hepatitis C called alisporivir, according to the product’s manufacturer.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com